Does ROSUVASTATIN Cause Dyspnoea at rest? 74 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 74 reports of Dyspnoea at rest have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.2% of all adverse event reports for ROSUVASTATIN.
74
Reports of Dyspnoea at rest with ROSUVASTATIN
0.2%
of all ROSUVASTATIN reports
0
Deaths
68
Hospitalizations
How Dangerous Is Dyspnoea at rest From ROSUVASTATIN?
Of the 74 reports, 68 (91.9%) required hospitalization.
Is Dyspnoea at rest Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 74 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Dyspnoea at rest?
TREPROSTINIL (314)
OMALIZUMAB (145)
MACITENTAN (140)
BISOPROLOL (136)
AMBRISENTAN (124)
ASPIRIN (108)
RAMIPRIL (101)
PANTOPRAZOLE (98)
AMLODIPINE (96)
ATORVASTATIN (92)
Which ROSUVASTATIN Alternatives Have Lower Dyspnoea at rest Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN